Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages

  Tendulkar, Rahul D ^a   Rehman, Sana ^a   Shukla, Monica E ^a   Reddy, Chandana A ^a   Moore, Halle ^a   Budd, G Thomas ^a   Dietz, Jill ^a   Crowe, Joseph P ^a   MacKlis, Roger ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Lymph nodes; Mastectomy; Radiation therapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CLEVELAND; CONFIDENCE INTERVAL; ESTROGEN RECEPTOR; HAZARD RATIO; HORMONAL THERAPY; LOCOREGIONAL RECURRENCE; LYMPH NODE; LYMPHOVASCULAR INVASIONS; MASTECTOMY; MULTI VARIATE ANALYSIS; POSITIVE LYMPH NODES; POSTMASTECTOMY RADIATION THERAPIES; RISK FACTORS; SURVIVAL RATE; SYSTEMIC THERAPY; TRASTUZUMAB; UNIVARIATE ANALYSIS;

BODY FLUIDS; CHEMOTHERAPY; DISEASES; MONOCLONAL ANTIBODIES;

RADIOTHERAPY;

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MASTECTOMY; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; OHIO; POSTOPERATIVE PERIOD; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84863634410     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.076     Document Type: Article

References (20)

1. J. Ragaz, I.A. Olivotto, and J.J. Spinelli Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 116 126
2. M. Overgaard, P.S. Hansen, and J. Overgaard Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med 337 1997 949 955
3. M. Overgaard, M.B. Jensen, and J. Overgaard Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet 353 1999 1641 1648
4. A. Recht, S.B. Edge, and L.J. Solin Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 19 2001 1539 1569
5. J.R. Harris, P. Halpin-Murphy, and M. McNeese Consensus statement on postmastectomy radiation therapy Int J Radiat Oncol Biol Phys 44 1999 989 990
6. M. Overgaard, H.M. Nielsen, and J. Overgaard Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 B&C randomized trials Radiother Oncol 82 2007 247 253
7. L.B. Marks, J. Zeng, and L.R. Prosnitz One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate J Clin Oncol 26 2008 2075 2077
8. S.H. Cheng, C.F. Horng, and J.L. Clarke Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients Int J Radiat Oncol Biol Phys 64 2006 1401 1409
9. J.C. Cheng, C.M. Chen, and M.C. Liu Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy Int J Radiat Oncol Biol Phys 52 2002 980 988
10. B. Fowble, R. Gray, and K. Gilchrist Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy J Clin Oncol 6 1988 1107 1117
11. P.T. Truong, I.A. Olivotto, and H.A. Kader Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy Int J Radiat Oncol Biol Phys 61 2005 1337 1347
12. P.T. Truong, E. Berthelet, and J. Lee The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes Cancer 103 2005 2006 2014
13. P.S. Yang, C.M. Chen, and M.C. Liu Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status Int J Radiat Oncol Biol Phys 77 2010 516 522
14. A. Katz, E.A. Strom, and T.A. Buchholz Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation J Clin Oncol 18 2000 2817 2827
15. M. Baum, A.U. Budzar, and J. Cuzick Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Lancet 359 2002 2131 2139
16. M.L. Citron, D.A. Berry, and C. Cirrincione Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 J Clin Oncol 21 2003 1431 1439
17. E.P. Mamounas, J. Bryant, and B. Lembersky Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28 J Clin Oncol 23 2005 3686 3696
18. E.H. Romond, E.A. Perez, and J. Bryant Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684
19. A. Taghian, J.H. Jeong, and E. Mamounas Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials J Clin Oncol 22 2004 4247 4254
20. A. Recht, R. Gray, and N.E. Davidson Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group J Clin Oncol 17 1999 1689 1700